Utah Medical Products ($UTMD) has extended its $75-per-share self-tender by almost three weeks, moving the expiration from October 7 to October 27.
The company said the extension gives shareholders more time to decide and, specifically, lets them see UTMD’s third-quarter results before the tender closes. Those results are scheduled for October 22, five days before the new deadline.
For the odd-lot trade we began tracking in September, the economics have changed even though the tender price has not. The same potential gross profit now requires substantially more time in the position and carries an earnings event before expiration.
The $75 price and 650,000-share limit are unchanged
UTMD is still offering to buy up to 650,000 shares at $75 each. The October 5 Schedule TO amendment changes the expiration date to 5:00 p.m. New York City time on October 27 and leaves the rest of the offer in place.
The original tender represented roughly 20% of UTMD’s shares outstanding when announced. If more shares are validly tendered than the company purchases, ordinary tenders can be prorated, while qualifying odd lots receive priority under the tender documents.
We covered the original setup in our September UTMD odd-lot article. At the September 15 reference price of $74.63, a hypothetical 99-share position cost $7,388.37 and offered $36.63 of gross profit if all 99 shares were purchased by UTMD at $75.
The extension cuts the return on time
The dollar profit in that paper trade has not changed: $36.63 before commissions, taxes and any other costs. The time required to earn it has.
Measured only from the September 15 reference date to the original October 7 expiration, the approximately 0.50% gross return annualized to about 8.2% on a simple basis. Extending the expiration to October 27 stretches the same calculation to 42 days and reduces that simple annualized figure to roughly 4.3%.
| Original Schedule | Extended Schedule | |
|---|---|---|
| Tender price | $75.00 | $75.00 |
| Expiration | Oct. 7 | Oct. 27 |
| 99-share paper-trade cost | $7,388.37 | $7,388.37 |
| Gross potential profit | $36.63 | $36.63 |
| Simple annualized gross return through expiration | ~8.2% | ~4.3% |
Those annualized figures are only a way to compare the holding periods. They do not account for the time between expiration and payment. The Offer to Purchase says that in previous UTMD tender offers, checks were mailed roughly two weeks after expiration, so the actual period during which capital may be tied up can be longer.
Q3 earnings now fall inside the tender period
UTMD said the extension allows shareholders to consider its calendar third-quarter results, which are scheduled for October 22. That creates an event inside what had been a short, relatively mechanical tender trade.
If the earnings report pushes UTMD materially above $75, tendering at $75 would become unattractive and a shareholder could consider withdrawing before the expiration deadline, subject to the tender procedures and any earlier broker cutoff. If the shares fall, the fixed $75 tender price becomes more valuable to an eligible holder as long as the offer remains in force and its conditions are satisfied.
The extension therefore adds both time and price risk. The original paper trade was already marginal because the spread was only $0.37 per share at our reference price. Adding 20 days and an earnings release makes that original setup less compelling even though the headline tender terms are unchanged.
The odd-lot preference is not a new trade for someone buying today
The filed tender materials condition odd-lot priority on having beneficially owned fewer than 100 shares by an earlier September eligibility date and continuing to own the qualifying position through expiration. A shareholder buying 99 shares after the extension was announced should not assume that the purchase qualifies for priority simply because the tender now remains open until October 27.
Our September 15 paper trade predates the eligibility dates in the filed tender materials, so that issue does not change the hypothetical position we have been tracking. Anyone dealing with an actual tender should follow the current Letter of Transmittal and broker instructions, particularly because broker submission deadlines can be earlier than the company’s formal expiration time.
Our paper trade stays open, but the extension makes it worse
For the experiment, we will continue to track the same hypothetical 99 shares purchased at $74.63. The potential tender proceeds remain $7,425 and the gross potential profit remains $36.63.
The extension removes one of the few attractions the trade had: a short timetable. UTMD has exchanged an October 7 exit for an October 27 decision date, with earnings arriving in between. Unless the economics change materially before the deadline, the paper trade remains a useful example of an odd-lot preference that is structurally attractive but financially thin.